SE518578C2 - Lipidbaserad komposition - Google Patents

Lipidbaserad komposition

Info

Publication number
SE518578C2
SE518578C2 SE9402106A SE9402106A SE518578C2 SE 518578 C2 SE518578 C2 SE 518578C2 SE 9402106 A SE9402106 A SE 9402106A SE 9402106 A SE9402106 A SE 9402106A SE 518578 C2 SE518578 C2 SE 518578C2
Authority
SE
Sweden
Prior art keywords
phase
composition according
biologically active
liquid crystalline
fatty acid
Prior art date
Application number
SE9402106A
Other languages
English (en)
Swedish (sv)
Other versions
SE9402106L (sv
SE9402106D0 (sv
Inventor
Helena Ljusberg-Wahren
Kaare Larsson
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Priority to SE9402106A priority Critical patent/SE518578C2/sv
Publication of SE9402106D0 publication Critical patent/SE9402106D0/xx
Priority to AT95922814T priority patent/ATE203399T1/de
Priority to US08/750,126 priority patent/US5807573A/en
Priority to PCT/SE1995/000593 priority patent/WO1995034287A1/fr
Priority to AU27563/95A priority patent/AU2756395A/en
Priority to JP50200796A priority patent/JP3825468B2/ja
Priority to CA002192190A priority patent/CA2192190C/fr
Priority to EP95922814A priority patent/EP0767656B1/fr
Priority to DE69521896T priority patent/DE69521896T2/de
Publication of SE9402106L publication Critical patent/SE9402106L/
Priority to FI964959A priority patent/FI964959A/fi
Priority to NO965380A priority patent/NO965380L/no
Publication of SE518578C2 publication Critical patent/SE518578C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
SE9402106A 1994-06-15 1994-06-15 Lipidbaserad komposition SE518578C2 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9402106A SE518578C2 (sv) 1994-06-15 1994-06-15 Lipidbaserad komposition
DE69521896T DE69521896T2 (de) 1994-06-15 1995-05-24 Präparat auf lipidbasis, das diacylglyzerin, ein phospholipid, eine polare flüssigkeit und biologisch aktives material enthält
AU27563/95A AU2756395A (en) 1994-06-15 1995-05-24 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material
US08/750,126 US5807573A (en) 1994-06-15 1995-05-24 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material
PCT/SE1995/000593 WO1995034287A1 (fr) 1994-06-15 1995-05-24 Composition lipidique a base de diacylglycerol, de phospholipide, de liquide polaire et de principe actif d'origine biologique
AT95922814T ATE203399T1 (de) 1994-06-15 1995-05-24 Präparat auf lipidbasis, das diacylglyzerin, ein phospholipid, eine polare flüssigkeit und biologisch aktives material enthält
JP50200796A JP3825468B2 (ja) 1994-06-15 1995-05-24 ジアシルグリセロール、リン脂質、極性液体および生物活性物質を含有する脂質をベースとした組成物
CA002192190A CA2192190C (fr) 1994-06-15 1995-05-24 Composition lipidique a base de diacylglycerol, de phospholipide, de liquide polaire et de principe actif d'origine biologique
EP95922814A EP0767656B1 (fr) 1994-06-15 1995-05-24 Composition lipidique a base de diacylglycerol, de phospholipide, de liquide polaire et de principe actif d'origine biologique
FI964959A FI964959A (fi) 1994-06-15 1996-12-11 Diasyyliglyserolia, fosfolipidiä, polaarista nestettä ja biologisesti aktiivista materiaalia sisältävä lipidipohjainen koostumus
NO965380A NO965380L (no) 1994-06-15 1996-12-13 Lipidbasert blanding inneholdende diacylglycerol, fosfolipid, polar væske og biologisk aktivt materiale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402106A SE518578C2 (sv) 1994-06-15 1994-06-15 Lipidbaserad komposition

Publications (3)

Publication Number Publication Date
SE9402106D0 SE9402106D0 (sv) 1994-06-15
SE9402106L SE9402106L (sv) 1995-12-16
SE518578C2 true SE518578C2 (sv) 2002-10-29

Family

ID=20394403

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402106A SE518578C2 (sv) 1994-06-15 1994-06-15 Lipidbaserad komposition

Country Status (11)

Country Link
US (1) US5807573A (fr)
EP (1) EP0767656B1 (fr)
JP (1) JP3825468B2 (fr)
AT (1) ATE203399T1 (fr)
AU (1) AU2756395A (fr)
CA (1) CA2192190C (fr)
DE (1) DE69521896T2 (fr)
FI (1) FI964959A (fr)
NO (1) NO965380L (fr)
SE (1) SE518578C2 (fr)
WO (1) WO1995034287A1 (fr)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
SE510363C2 (sv) * 1996-09-05 1999-05-17 Gs Dev Ab Användning av en flytande kristallin fas för att bestämma fördelningen av en kemisk substans mellan en hydrofob och en hydrofil miljö
SE511313C2 (sv) * 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
AU6919598A (en) * 1997-04-17 1998-11-13 Dumex-Alpharma A/S A novel bioadhesive drug delivery system based on liquid crystals
DK1014946T3 (da) 1997-09-18 2010-06-28 Pacira Pharmaceuticals Inc Liposomale anæstetiske sammensætninger med forsinket frigivelse
EP1030652B1 (fr) 1997-11-14 2012-04-25 Pacira Pharmaceuticals, Inc. Production de liposomes multivesiculaires
FR2780644B1 (fr) * 1998-07-03 2001-07-20 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse et d'une phase aqueuse, stabilisee a l'aide de particules de gel cubique
SE9802528D0 (sv) * 1998-07-13 1998-07-13 Gs Dev Ab Bone tissue restoring composition
SE514908C2 (sv) * 1998-07-13 2001-05-14 Gs Dev Ab Medel för benrekonstruktion
GB9827034D0 (en) * 1998-12-10 1999-02-03 Univ Manchester Delivery formulation
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
US6800298B1 (en) 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
DE10057769A1 (de) 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
DE10057770A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Hautpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen ,
US6610322B1 (en) * 2000-12-20 2003-08-26 Brian Charles Keller Self forming, thermodynamically stable liposomes and their applications
US6656385B2 (en) * 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6936187B2 (en) 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US20030096000A1 (en) * 2001-05-31 2003-05-22 Solis Rosa Maria Encapsulation of nanosuspensions in liposomes and microspheres
DE10127406A1 (de) * 2001-06-06 2002-12-12 Xzillion Gmbh & Co Kg Verfahren zur elektrophoretischen Trennung von Proben
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
PL1682091T3 (pl) * 2003-11-07 2017-09-29 Camurus Ab Kompozycje lipidów i kationowych peptydów
US8182834B2 (en) 2004-01-23 2012-05-22 Camurus Ab Ternary non-lamellar lipid compositions
EP1768650B1 (fr) * 2004-06-04 2008-07-16 Camurus Ab Formulations de depot liquide
GB0412530D0 (en) * 2004-06-04 2004-07-07 Camurus Ab Formulation
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
EP1843746B1 (fr) * 2005-01-14 2011-03-16 Camurus Ab Formulations à base d'analogues de somatostatine
US9649382B2 (en) * 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
DK1845942T3 (da) * 2005-01-14 2014-04-28 Camurus Ab GNRH-analogformuleringer
CA2594718C (fr) * 2005-01-14 2012-01-24 Camurus Ab Formulations d'analogues de gnrh
US8871712B2 (en) 2005-01-14 2014-10-28 Camurus Ab Somatostatin analogue formulations
JP5127466B2 (ja) * 2005-01-21 2013-01-23 カムルス エービー 医薬脂質組成物
GB0501364D0 (en) * 2005-01-21 2005-03-02 Camurus Ab Compositions
CN101217940B (zh) * 2005-06-06 2013-03-27 卡穆鲁斯公司 Glp-1类似物制剂
US20070020228A1 (en) * 2005-07-22 2007-01-25 Williams Terry N Method of using a biosealant device
US20070092462A1 (en) * 2005-10-24 2007-04-26 Julio Gans Russ Cosmetic compositions
WO2007061896A1 (fr) 2005-11-17 2007-05-31 Zogenix, Inc. Administration de preparations visqueuses par injection sans aiguille
CN101410172A (zh) * 2005-11-23 2009-04-15 雀巢技术公司 用于生成新制品稠度的水包油乳液
US8268347B1 (en) 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
US8333787B2 (en) 2007-12-31 2012-12-18 St. Jude Medical Puerto Rico Llc Vascular closure device having a flowable sealing material
US8568445B2 (en) 2007-08-21 2013-10-29 St. Jude Medical Puerto Rico Llc Extra-vascular sealing device and method
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
EP2052716B1 (fr) * 2007-10-24 2014-12-31 Camurus AB Formulations à libération contrôlée
US8840640B2 (en) 2007-12-31 2014-09-23 St. Jude Medical Puerto Rico Llc Vascular closure device having an improved plug
EP2756756B1 (fr) 2008-04-28 2016-01-06 Zogenix, Inc. Compositions inédites destinées au traitement de la migraine
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
EP2165706A1 (fr) 2008-09-18 2010-03-24 BioAlliance Pharma Traitement de la douleur inflammatoire de la muqueuse de la cavité buccale à l'aide de supports thérapeutiques bioadhésifs de muqueuse à libération prolongée
CA2743675A1 (fr) * 2008-11-14 2010-05-20 Shireen S. Baseeth Compositions et procedes de production d'organogel
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
WO2011075623A1 (fr) 2009-12-18 2011-06-23 Latitude Pharmaceuticals, Inc. Composition de gel à une phase comprenant des phospholipides
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9447187B2 (en) 2011-02-03 2016-09-20 Alexion Pharmaceuticals, Inc. Use of an anti-CD200 antibody for prolonging the survival of allografts
CN103547258B (zh) 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
SG11201402673YA (en) * 2011-12-05 2014-06-27 Camurus Ab Robust controlled-release formulations
MX350964B (es) 2012-05-25 2017-09-27 Camurus Ab Formulaciones de agonistas del receptor de somatostatina.
KR102098980B1 (ko) 2012-07-26 2020-04-08 카무러스 에이비 오피오이드 제형
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
KR101586790B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
SG11202000629QA (en) 2017-07-27 2020-02-27 Allergan Inc Prostacyclin receptor agonists for reduction of body fat
JP7064612B2 (ja) * 2018-09-20 2022-05-10 富士フイルム株式会社 生体材料
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
CN117794519A (zh) * 2021-07-27 2024-03-29 法纳克斯株式会社 非层状液晶形成性组合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
US5196201A (en) * 1989-10-20 1993-03-23 Bioapatite Ab Implant material composition, preparation thereof as well as uses thereof and implant product obtainable therefrom
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5164191A (en) * 1991-02-12 1992-11-17 Micro Vesicular Systems, Inc. Lipid vesicles having an alkyd as a wall-forming material
PT100502A (pt) * 1991-05-20 1993-08-31 Alza Corp Composicoes farmaceuticas para aumentar a capacidade de permeacao na pele utilizando monolinoleato de glicerol

Also Published As

Publication number Publication date
FI964959A0 (fi) 1996-12-11
JPH10504532A (ja) 1998-05-06
NO965380D0 (no) 1996-12-13
FI964959A (fi) 1996-12-11
DE69521896D1 (de) 2001-08-30
WO1995034287A1 (fr) 1995-12-21
DE69521896T2 (de) 2001-11-22
JP3825468B2 (ja) 2006-09-27
SE9402106L (sv) 1995-12-16
CA2192190A1 (fr) 1995-12-21
ATE203399T1 (de) 2001-08-15
US5807573A (en) 1998-09-15
EP0767656A1 (fr) 1997-04-16
AU2756395A (en) 1996-01-05
NO965380L (no) 1996-12-13
EP0767656B1 (fr) 2001-07-25
SE9402106D0 (sv) 1994-06-15
CA2192190C (fr) 2004-09-21

Similar Documents

Publication Publication Date Title
SE518578C2 (sv) Lipidbaserad komposition
KR100220546B1 (ko) 호지성 담체 제제
US5665379A (en) Lipid particle forming matrix, preparation and use thereof
JPH0347527A (ja) 水相中に油粒子のナノエマルジヨンを製造する方法、薬学および化粧品調剤の製法および細胞培養用栄養溶液の製法
HUT74423A (en) Pharmaceutical basic compositions
AU645143B2 (en) Lipid formulation system
KR100446832B1 (ko) 장벽을 통한 활성성분의 비침습성 도포 또는 운반용 제제를 제조하기 위한 액체 소적
JPH0798740B2 (ja) 薬物担体
US20030113351A1 (en) Lipid carrier
WO2000032219A1 (fr) Composition pharmaceutique contenant cyclosporine dans un vehicule lipidique
CN112190504B (zh) 一种含有玫瑰精油的长效液体凝胶及其制备方法和应用
CN101049504A (zh) 一种脂质体药物载体及其制备方法
RU2740553C2 (ru) Способ получения липосомальной формы бетулина, обладающей гепатопротекторной активностью
RU2127124C1 (ru) Препараты липофильных носителей
WO2003020319A1 (fr) Composition support d'emulsion eau dans huile

Legal Events

Date Code Title Description
NUG Patent has lapsed